Novel Approaches Used to Examine and Control Neurogenesis in Parkinson′s Disease

• Published in: International journal of molecular sciences Vol. 22; no. 17; p. 9608
• Main Authors: Salmina, Alla B., Kapkaeva, Marina R., Vetchinova, Anna S., Illarioshkin, Sergey N.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2021; MDPI
• Subjects: astrocyte; Astrocytes; Brain; Cell differentiation; Deregulation; Developmental plasticity; Functional integration; Genetics; In vivo methods and tests; Inflammation; Information processing; Kinases; Neural plasticity; neural progenitor cell; neural stem cell; Neural stem cells; Neurodegeneration; Neurogenesis; Neurons; Neurotoxicity; Parkinson's disease; Phenotypes; Progenitor cells; Review; Stem cells; Synaptic plasticity; Synuclein; α-synuclein
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22179608

Neurogenesis is a key mechanism of brain development and plasticity, which is impaired in chronic neurodegeneration, including Parkinson’s disease. The accumulation of aberrant α-synuclein is one of the features of PD. Being secreted, this protein produces a prominent neurotoxic effect, alters synaptic plasticity, deregulates intercellular communication, and supports the development of neuroinflammation, thereby providing propagation of pathological events leading to the establishment of a PD-specific phenotype. Multidirectional and ambiguous effects of α-synuclein on adult neurogenesis suggest that impaired neurogenesis should be considered as a target for the prevention of cell loss and restoration of neurological functions. Thus, stimulation of endogenous neurogenesis or cell-replacement therapy with stem cell-derived differentiated neurons raises new hopes for the development of effective and safe technologies for treating PD neurodegeneration. Given the rapid development of optogenetics, it is not surprising that this method has already been repeatedly tested in manipulating neurogenesis in vivo and in vitro via targeting stem or progenitor cells. However, niche astrocytes could also serve as promising candidates for controlling neuronal differentiation and improving the functional integration of newly formed neurons within the brain tissue. In this review, we mainly focus on current approaches to assess neurogenesis and prospects in the application of optogenetic protocols to restore the neurogenesis in Parkinson’s disease.